HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frederick W Larsen Selected Research

ganirelix

11/2006Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome.
1/2006Treatment with gonadotropin-releasing hormone (GnRH) antagonists in women suppressed with GnRH agonist may avoid cycle cancellation in patients at risk for ovarian hyperstimulation syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frederick W Larsen Research Topics

Disease

2Ovarian Hyperstimulation Syndrome
11/2006 - 01/2006
1Hemorrhage
10/2004
1Postpartum Hemorrhage
10/2004

Drug/Important Bio-Agent (IBA)

2ganirelixFDA Link
11/2006 - 01/2006
2Leuprolide (Lupron)FDA LinkGeneric
11/2006 - 01/2006
1Estradiol (Delestrogen)FDA LinkGeneric
11/2006
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2006

Therapy/Procedure

1Sutures (Suture)
10/2004
1Braces
10/2004